Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $3.3650 (5.65%) ($3.3650 - $3.3650) on Thu. Aug. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.74% (three month average) | RSI | 37 | Latest Price | $3.3650(5.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLU(47%) LIT(46%) SPLV(46%) EWP(44%) XBI(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.87% in a week (0% probabilities). CEMB(6%) XRT(7%) XOP(7%) EDOC(8%) BNDX(8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.87% (StdDev 9.74%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-85.49(-2640.56%) | Resistance Level | $4.05 | 5 Day Moving Average | $3.08(9.25%) | 10 Day Moving Average | $3.15(6.83%) | 20 Day Moving Average | $4.05(-16.91%) | To recent high | -61.7% | To recent low | 17.9% | Market Cap | $250m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |